How Big Is the Gene Editing Market | Insights & Forecasts 2031

Q: How big is the gene editing market?

The gene editing market was valued at USD 6.1 Billion in 2024 and is expected to reach USD 10.54 Billion by 2031

Q: What factors are driving the gene editing market?

Major drivers include rising disease burden, CRISPR advancements, and demand for precision medicine.

Q: Who are the top companies in the gene editing market?

Top players of the market include CRISPR Therapeutics, Editas, Intellia, Beam, and Thermo Fisher.

Q: What are some recent trends in the market?

Trends include base editing, clinical CRISPR trials, AI-driven gene mapping, and expanded agricultural use.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6125

Publication Date: Jul 2025

What is the size of the Gene Editing Market?

According to 6Wresearch internal database and industry insights, the Global Gene Editing Market was valued at USD 6.1 Billion in 2024 and is expected to reach USD 10.54 Billion by 2031, growing at a compound annual growth rate of 5.50% during the forecast period (2025-2031).

Due to advancements in CRISPR technology, increased funding for genomic research and investments, rising demand for personalized medicines and growing biotech applications, the gene editing market is predicted for the exceptional growth in the forthcoming years.

View Main Report

Schedule Analyst Call

Key Growth Drivers of the Gene Editing Market

Increasing prevalence of genetic disorders and chronic diseases
Advancements in CRISPR, TALENs, and ZFN technologies
Expanding applications in agriculture, healthcare, and research
Rising investments from pharma and biotech companies
Supportive government initiatives and funding for genome research

Gene Editing Market Trends

Gene editing market is experiencing growth over the years with CRISPR-based therapies which are entering clinical pipelines for rare diseases and cancer. Gene editing is enabling development of targeted treatments. At the other side, the personalized medicine is driving adoption in oncology and inherited conditions. Further, the gene-editing tools are also being optimized for precision and safety.

This market is seeing rise of AI integration for gene targeting and outcome prediction and there is expansion of gene editing in livestock and crop trait improvement.

Emerging Developments in the Gene Editing Market

Gene editing is seeing developments as moving from research to clinical and commercial applications. Ex vivo and in vivo therapies are under active regulatory review. Alongside, the next-gen tools are being developed for base editing and prime editing. Further, the startups are innovating with delivery systems for safe genome modification. Also, global partnerships are being formed to scale rare disease trials. Focus is increasing on ethical guidelines, safety assessments, and public acceptance.